CVS: 2019 To Be Year Of Transition Amid Drug Pricing Pressures

CVS Health chief executive Larry Merlo said the company expects some “headwinds” as the drugstore chain integrates Aetna into the business amid drug pricing pressures and an underperforming Omnicare long-term care business.

Read the full post on Forbes - Healthcare